Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Transient infection of eukaryotic cells with commensal and extraintestinal pathogenic Escherichia coli of phylogenetic group B2 blocks mitosis and induces megalocytosis. This trait is linked to a widely spread genomic island that encodes giant modular nonribosomal peptide and polyketide synthases. Contact with E. coli expressing this gene cluster causes DNA double-strand breaks and activation of the DNA damage checkpoint pathway, leading to cell cycle arrest and eventually to cell death. Discovery of hybrid peptide-polyketide genotoxins in E. coli will change our view on pathogenesis and commensalism and open new biotechnological applications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In line with that, many preclinical studies performed using germ-free mice models demonstrated how the gut microbiome is able to deeply affect cancer genesis and progression through different mechanisms [33,54,55].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [55]
In the citing paper
“Accordingly, we observed that pksC E. coli infection, which is known to induce DNA damage, 9,10 induced c-Myc expression and its binding to the miR-20a-5p promoter.”
From The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment (2014) · cites this paper as [9]
Citations
Cites
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583
DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139
Rogakou, E. P., Pilch, D. R., Orr, A. H., Ivanova, V. S., & Bonner, W. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5858 · Cited by 5,438
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
DNA double-strand breaks: signaling, repair and the cancer connection
Khanna, K. K., & Jackson, S. P. (2001) · Nature Genetics · doi:10.1038/85798 · Cited by 2,455
Welch, R. A., Burland, V., Plunkett, G., Redford, P., Roesch, P., Rasko, D., Buckles, E. L., Liou, S.-R., Boutin, A., Hackett, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252529799 · Cited by 1,531
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285
Rembacken, B., Snelling, A., Hawkey, P., Chalmers, D., & Axon, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06343-0 · Cited by 1,101
(1999) · PubMed · Cited by 1,030
The Link between Phylogeny and Virulence in Escherichia coli Extraintestinal Infection
Picard, B., Garcia, J. S., Gouriou, S., Duriez, P., Brahimi, N., Bingen, E., Elion, J., & Denamur, E. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.546-553.1999 · Cited by 794
Research works printed but not linked: 1
- J. N. Sarkaria et al., Cancer Res.59, 4375 (1999).
Cited by
Items 801–900 of 999
Small Animals Gut Microbiome and Its Relationship with Cancer
Ferrarias, T. M., & Santos, A. A. F. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95780 · Cited by 9
Ji, H., Qiao, O., Zhang, Y., Wang, W., Han, X., Zhang, X., Liu, C., & Gao, W. (2023) · Phytotherapy Research · doi:10.1002/ptr.7924 · Cited by 7
“Besides, bacterial toxins or reactive oxygen/nitrogen secreted by the above-mentioned species directly or indirectly drive malignant transformation of the lung epithelium through TP53 mutations (Nougayrède et al., 2006; Guerra et al., 2011).”
Rebai, Y., Wagner, L., Gnaien, M., Hammer, M. L., Kapitan, M., Niemiec, M. J., Mami, W., Mosbah, A., Messadi, E., Mardassi, H., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11081929 · Cited by 8
“EcN also synthesizes a genotoxin called colibactin, which induces DNA crosslinks, double-strand breaks and chromosome aberrations in eukaryotic cells [42].”
BackgroundZulpa, A. K., Barathan, M., Iyadorai, T., Mariappan, V., Vadivelu, J., Teh, C. S. J., & Vellasamy, K. M. (2023) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-023-03767-1 · Cited by 7
Relevance of harmful intratumoral microbiota in cancer progression and its clinical application
Yu, R., Wang, S., & Han, L. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117238 · Cited by 9
Intratumoral Microbiota: Insights from Anatomical, Molecular, and Clinical Perspectives
Lombardo, C., Fazio, R., Sinagra, M., Gattuso, G., Longo, F., Lombardo, C., Salmeri, M., Zanghì, G., & Loreto, C. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14111083 · Cited by 8
Impact of gut microbiota and its metabolites on immunometabolism in colorectal cancer
Flory, M., Bravo, P., & Alam, A. M. (2024) · Immunometabolism · doi:10.1097/in9.0000000000000050 · Cited by 11
Kim, C. S., Turocy, T., Moon, G., Shine, E. E., & Crawford, J. M. (2021) · Organic Letters · doi:10.1021/acs.orglett.1c02461 · Cited by 8
Structure and function of prodrug-activating peptidases
Velilla, J., Kenney, G. E., & Gaudet, R. (2022) · Biochimie · doi:10.1016/j.biochi.2022.07.019 · Cited by 9
Targeted depletion of pks + bacteria from a fecal microbiota using specific antibodies
Blanco‐Míguez, A., Marcos-Fernández, R., Guadamuro, L., Fdez‐Riverola, F., Cubiella, J., Lourenço, A. M. G., Margollés, A., & Sánchez, B. (2023) · mSystems · doi:10.1128/msystems.00079-23 · Cited by 8
“Moreover, one such commensal, the probiotic strain Nissle 1917, commercialized as Mutaflor and efficacy and safety in maintaining remission of intestinal inflammation (28), contains the pks island and produces a functional genotoxin (2).”
BackgroundMethodInfluentialIshikawa, F., & Kakeya, H. (2016) · ChemBioChem · doi:10.1002/cbic.201500553 · Cited by 7
Are we any closer to screening for colorectal cancer using microbial markers?A critical review
Starý, L., Mezerová, K., Skalický, P., Zbořil, P., & Raclavský, V. (2017) · Biomedical Papers · doi:10.5507/bp.2017.051 · Cited by 9
A mutational signature that can be made by a bacterium arises in human colon cancer
Yang, Y., & Jobin, C. (2020) · Nature · doi:10.1038/d41586-020-00818-7 · Cited by 7
Hussein, M. T., Al-Qaysi, S. A. S., Rathi, M. H., Hussein, Q. I., & Moussa, T. A. A. (2020) · Baghdad Science Journal · doi:10.21123/bsj.2020.17.3(suppl.).1113 · Cited by 7
“These molecules are considered as secondary metabolites, and their biosynthesis is encoded by specific gene cluster which was firstly identified and characterized by Oswald with many co-workers during 2006 in an extra-intestinal pathogenic Escherichia coli strain (ExPEC) isolated from neonatal meningitis (1,2).”
BackgroundRecent Advances in the Role of Microorganisms in Cancer Incidence: Mechanisms and Health Precautions
Yahya, E. B., Abdulsamad, M. A., & Allaq, A. A. (2021) · Biomedical Research and Therapy · doi:10.15419/bmrat.v8i9.691 · Cited by 10
Herzon, S. B. (2020) · Nature Chemistry · doi:10.1038/s41557-020-00551-8 · Cited by 8
Microbiome in Colonic Carcinogenesis
Sun, J., & Xia, Y. (2023) · Comprehensive physiology · doi:10.1002/cphy.c210052 · Cited by 11
Dubbert, S., & von Bünau, R. (2021) · mSphere · doi:10.1128/msphere.00856-21 · Cited by 6
“of colibactin is observed only following direct cell-cell contact (6), plus the transcriptional activation of all clb genes of the pks island seems to be required (12).”
BackgroundIntratumoral microbiota as cancer therapeutic target
Guo, C., An, Q., Zhang, L., Wei, X., Xu, J., Yu, J., Wu, G., & Ma, J. (2024) · Aging Medicine · doi:10.1002/agm2.12359 · Cited by 7
Khan, Z. A., Song, S., Xu, H., Ahmad, M., Wang, A., Abdullah, A., Jiang, L., & Ding, X. (2025) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107471 · Cited by 7
L-serine promotes pro-carcinogenic effects of colibactin-producing E. coli
Devaux, A., Villéger, R., Roche, G., Diémé, B., Rodrigues, M., Juban, C., Lagrée, M., Venisse, N., Jousse, C., Barnich, N., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2515480 · Cited by 9
Jia, R., Martin, L. A., Saraiva, M., Sifré, E., Dubus, P. R., Varon, C., & Ménard, A. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf312 · Cited by 6
McElderry, J. P., Zhang, T., Wei, Z., Hoang, P. H., Anyaso-Samuel, S., Sang, J., Khandekar, A., Hartman, C., Colón-Matos, F. J., Miraftab, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66780-y · Cited by 10
Popov, J., Caputi, V., Nandeesha, N., Rodriguez, D. A., & Pai, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111365 · Cited by 98
Drug delivery systems for enhanced tumour treatment by eliminating intra-tumoral bacteria
Liu, Z., Ma, Y., Ye, J.-X., Li, G., Kang, X., Xie, W., & Wang, X. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02362a · Cited by 7
Microbiome Sex-Related Diversity in Non-Muscle-Invasive Urothelial Bladder Cancer
Bilski, K., Żeber‐Lubecka, N., Kulecka, M., Dąbrowska, M., Bałabas, A., Ostrowski, J., Dobruch, A., & Dobruch, J. T. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46040225 · Cited by 6
“Escherichia coli of the phylogenetic group B2 induces DNA double-strand breaks in intestinal epithelial cells [54].”
BackgroundImmunomodulation aspects of gut microbiome-related interventional strategies in colorectal cancer
Cheraghpour, M., Fatemi, N., Shadnoush, M., Talebi, G., Tierling, S., & Bermúdez‐Humarán, L. G. (2024) · Medical Oncology · doi:10.1007/s12032-024-02480-9 · Cited by 8
Microbiota mechanisms in cancer progression and therapy
Zhang, X., Fam, K. T., Dai, T., & Hang, H. C. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.04.005 · Cited by 9
Structural study on human microbiome-derived polyketide synthases that assemble genotoxic colibactin
Kim, M., Kim, J., Lee, G. S., Olinares, P. D. B., Airan, Y., Chow, J. L., Park, J., Jeong, Y., Park, J., Chait, B. T., et al. (2025) · Structure · doi:10.1016/j.str.2025.04.017 · Cited by 8
Microbiome and the Hallmarks of Cancer
Bleich, R. M., & Arthur, J. C. (2021) · Physiology in health and disease · doi:10.1007/978-3-030-67951-4_1 · Cited by 8
Liu, J., Xu, Z., Li, H., Chen, F., Han, K., Hu, X., Fang, Y., & Chen, D. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02190-21 · Cited by 10
Pragmatic Expectancy on Microbiota and Non-Small Cell Lung Cancer: A Narrative Review
Stella, G. M., Scialò, F., Bortolotto, C., Agustoni, F., Sanci, V., Saddi, J., Casali, L., Corsico, A. G., & Bianco, A. (2022) · Cancers · doi:10.3390/cancers14133131 · Cited by 7
DeLira-Bustillos, N., Zamudio, U. A. A., León-Sicairos, N. M., Flores-Villaseñor, H. M., Velazquez-Roman, J. A., Tapia-Pastrana, G., Martínez‐Villa, F. A., Velázquez‐Cruz, R., Salmerón, J., Canizales‐Quinteros, S., et al. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106634 · Cited by 8
Ammosamides Unveil Novel Biosynthetic Machinery
Colosimo, D. A., & MacMillan, J. B. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.12.001 · Cited by 6
“…fuel industrial production of molecules whose importance has already been demonstrated (Galanie et al., 2015), to understand ways in which microbes interact with their environment using chemical signals (Nougayrède et al., 2006), and to discover new enzymatic capabilities (Gaudelli et al., 2015).”
BackgroundVillar-Ortega, P., Ruíz, M. E., Gutiérrez-Soto, M., Jiménez, M. R.-C., Navarro‐Marí, J. M., & Fernández, J. G. (2021) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2021.01.005 · Cited by 6
Structure elucidation of colibactinPreprint
Xue, M., Kim, C. S., Healy, A. R., Wernke, K. M., Wang, Z., Frischling, M. C., Shine, E. E., Wang, W., Herzon, S. B., & Crawford, J. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/574053 · Cited by 6
Screening method toward ClbP-specific inhibitors
Zhou, T., Ando, T., Kudo, A., Sato, M., Miyoshi, N., Mutoh, M., Ishikawa, H., Wakabayashi, K., & Watanabe, K. (2023) · Genes and Environment · doi:10.1186/s41021-023-00264-7 · Cited by 5
“It is biosynthesized via a PKS–NRPS hybrid pathway encoded within a 54-kilobase genomic island called pks or clb [1].”
BackgroundMethodBayne, C. F., Boutard, M., Zaplana, T., & Tolonen, A. C. (2024) · mSystems · doi:10.1128/msystems.00992-24 · Cited by 5
“The pH in cultures can be measured in real-time based on the fluorescence of BCECF [2,7-bis-(2-carboxyethyl)5-(and 6)-carboxyfluorescein] (25, 26).”
MethodLuévano, J. M., Liu, J. C., & Stappenbeck, T. S. (2025) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000864 · Cited by 6
“Studies have demonstrated potential pathways by which pathogenic bacteria alter the luminal microenvironment in a way that is conducive to the pathogenesis of CRC (41,46,48,52,54,55,57,108 – 112).”
Cystic fibrosis and inflammatory bowel disease: parallels in gut physiology and microbiota
Barrack, K. E., & O’Toole, G. A. (2025) · Journal of Bacteriology · doi:10.1128/jb.00167-25 · Cited by 6
Qian, Y., Lin, X., Huang, S., Chen, S., Wei, J., Pu, H., Lin, Y., Zhang, R., Xu, J., Li, J., et al. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.5c01135 · Cited by 5
Yang, X., Zhang, K., Xia, L., & Li, J. (2026) · iMetaMed · doi:10.1002/imm3.70030 · Cited by 5
Advancements in Understanding and Preventing Obesity-Related Colon Cancer
Shieh, C., Thompson, H. J., McLaughlin, E. M., Chiang, C., & Hussan, H. (2024) · The Cancer Journal · doi:10.1097/ppo.0000000000000744 · Cited by 5
Dey, S., Ghosh, M., & Dev, A. (2024) · Gene · doi:10.1016/j.gene.2024.149099 · Cited by 5
Dougherty, M. W., Hoffmann, R. M., Hernandez, M. C., Airan, Y., Gharaibeh, R. Z., Herzon, S. B., Yang, Y., & Jobin, C. (2025) · mSphere · doi:10.1128/msphere.00692-24 · Cited by 6
Sequence modeling tools to decode the biosynthetic diversity of the human microbiome
Dason, M. S., Corà, D., & Re, A. (2025) · mSystems · doi:10.1128/msystems.00333-25 · Cited by 6
“One of them is the potent genotoxic colibactin (99), which is encoded by various Escherichia coli strains belonging to the B2-phylogroup and has been strongly implicated in the development of colorectal cancer (100).”
Immune-mediated Bowel Disease: Role of Intestinal Parasites and Gut Microbiome
Chowdhury, S. R., Dey, A., Mondal, S., Pawar, S. D., Ranade, A., Mahajon, B., Bora, M., Rath, C., Teli, A., & Gautam, M. K. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128326270240816075025 · Cited by 7
Die Mikroben in uns und der Wettlauf um die Struktur und Biosynthese von Colibactin
Bode, H. B. (2015) · Angewandte Chemie · doi:10.1002/ange.201505341 · Cited by 5
An overview of cancer and the human microbiome
Mahapatra, S., Mohanty, S., Mishra, R., & Prasad, P. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.07.007 · Cited by 7
Wang, Y., Lu, M., Li, Y.-T., Tang, H., Hsiao, P.-Y., Chen, B.-H., Teng, R.-H., Chiou, C., & Lai, Y. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02077-22 · Cited by 5
Gut Microbiome Influence on Human Epigenetics, Health, and Disease
Watson, M. M., van der Giezen, M., & Søreide, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91909-8.00012-8 · Cited by 7
Influence of pathogens on host genome and epigenome in development of head and neck cancer
Desai, S. (2023) · Cancer Reports · doi:10.1002/cnr2.1846 · Cited by 5
“68 Building on this study, Pleguezuelos-Manzano C., et al., identified a mutation signature induced by colibactin – a protein encoded by PKS genes, produced by the pks + E. coli .”
BackgroundMicrobiome and Diseases: Colorectal Cancer
Iftekhar, A., Sperlich, A., Janssen, K., & Sigal, M. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90545-7_15 · Cited by 7
Morgan, R. N., Farrag, H. A., Aboulwafa, M., & Saleh, S. E. (2021) · Current Microbiology · doi:10.1007/s00284-020-02331-6 · Cited by 7
Jones, C. V., Jarboe, B., Majer, H. M., Ma, A. T., & Beld, J. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11546-x · Cited by 5
In situ analysis of the higher-order genome structure in a single Escherichia coli cell
Shindo, E., Kubo, K., Ohniwa, R. L., Takeyasu, K., & Yoshikawa, K. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.08.026 · Cited by 5
“The so-called comet assay has been frequently used to examine the genome structure (Nougayrède et al., 2006; Tice et al., 2000).”
MethodKinetic model for dynein oscillatory activity
Goldstein, B. N., Aksirov, A. M., & Zakrjevskaya, D. T. (2008) · Biophysical Chemistry · doi:10.1016/j.bpc.2007.12.009 · Cited by 5
Hybrid Peptide–Polyketide Natural Product Biosynthesis
Steele, A. D., Kalkreuter, E., Pan, G., Meng, S., & Shen, B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.14669-4 · Cited by 5
Microbiome-TP53 Gene Interaction in Human Lung CancerPreprint
Greathouse, K. L., White, J. R., Vargas, A. J., Bliskovsky, V. V., Beck, J. A., von Muhlinen, N., Polley, E. C., Bowman, E. D., Ma, K., Robles, A. I., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/273524 · Cited by 5
Wallenstein, A., Rehm, N., Brinkmann, M., Selle, M., Bossuet‐Greif, N., Sauer, D., Bunk, B., Spröer, C., Wami, H. T., Homburg, S., et al. (2020) · mSphere · doi:10.1128/msphere.00727-20 · Cited by 6
“To see whether the clbR promoter activity would respond to the growth medium and growth phase to the same extent as that seen with other E. coli isolates, we integrated the same the clbRp-lux reporter module used in E. coli M1/5 into the chromosomal -attB site of different model strains, in which colibactin expression…”
BackgroundMethodInfluentialSaito, S., Banno, T., & Arai, M. A. (2023) · Bioscience Biotechnology and Biochemistry · doi:10.1093/bbb/zbad172 · Cited by 4
Wachsmannová, L., Dulanská, S., Karhánek, M., Števurková, V., Čierniková, S., Repiská, V., Styk, J., Šoltýs, K., & Trnka, M. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-025-00177-7 · Cited by 4
“On the contrary, Escherichia-Shigella is highly enriched in the proximal colons, but some species of Escherichia coli, which harbour islands of polyketide synthase (pks) that encode genoflorin, can induce single-stranded DNA breaks [48] and may be associated with the first stages of CRC.”
The gut microbiota and colorectal cancer: Molecular insights and translational implications
Chen, J., Du, X., Shao, M., Sun, Y., Shi, X., & He, S. (2025) · Clinical Surgical Oncology · doi:10.1016/j.cson.2025.100107 · Cited by 5
Metabolite-mediated mechanisms linking the urinary microbiome to bladder cancer
Trần, T. A., Lee, H. Y., & Choi, H. W. (2025) · The Journal of Microbiology · doi:10.71150/jm.2509001 · Cited by 5
“Among them, Escherichia coli strains carrying the pks pathogenicity island can produce colibactin, a genotoxin known to alkylate adenine residues and cause double-strand DNA breaks in cultured cells (Nougayrède et al., 2006).”
Shekar, P. K., Pradeep, S., Shivamallu, C., Prashant, A., & Vishwanath, P. M. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-025-04197-1 · Cited by 5
“Host polymorphisms in immune-modulatory genes (e.g., TLR4, NOD2) further shape microbial composition, underlining the importance of personalized microbiome mapping in CRC risk stratification and therapy selection [12].”
Chen, H., Lou, G., Meng, F., Zhang, Y., Kuang, H., & Yang, D. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1734792 · Cited by 5
Wang, Q., Wang, X., Xie, Z., Qu, J., Lin, Y., Hu, J., Li, L., & Zhang, L. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s522818 · Cited by 4
Narita, T., Tsunematsu, Y., Miyoshi, N., Komiya, M., Hamoya, T., Fujii, G., Yoshikawa, Y., Sato, M., Kawanishi, M., Sugimura, H., et al. (2022) · In Vivo · doi:10.21873/invivo.12746 · Cited by 4
Trottmann, F., Franke, J., Richter, I., Ishida, K., Cyrulies, M., Dahse, H., Regestein, L., & Hertweck, C. (2019) · Angewandte Chemie · doi:10.1002/ange.201907324 · Cited by 4
Visual analysis of colorectal cancer and gut microbiota: A bibliometric analysis from 2002 to 2022
Long, D., Mao, C., Zhang, Z., Zou, J., & Zhu, Y. (2023) · Medicine · doi:10.1097/md.0000000000035727 · Cited by 4
“[40] pks + E. coli can produce the genotoxin colibactin, which can induce host cell DNA double-strand breaks, chromosomal instability, gene mutations, and cell cycle arrest, [78,79] and ultimately lead to cellular senescence or apoptosis.”
BackgroundIwasaka, C., Ninomiya, Y., Nakagata, T., Nanri, H., Watanabe, D., Ohno, H., Tanisawa, K., Konishi, K., Murakami, H., Tsunematsu, Y., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-47442-9 · Cited by 4
“…group, which has a genomic island called polyketide synthetase ( pks + E. coli ), might be involved in the development of CRC 6–12 . pks + E. coli encodes the genotoxin colibactin, which induces DNA damage, cell cycle arrest, mutations, and chromosomal instability in eukaryotic cells 7, 8, 13 .”
The Effect of H. pylori Infection on the Gastric Microbiota
Kim, N., & Jo, H. J. (2023) · Springer eBooks · doi:10.1007/978-981-97-0013-4_59 · Cited by 5
Uchiyama, H., Kudo, T., Yamaguchi, T., Obana, N., Watanabe, K., Abe, K., Miyazaki, H., Toyofuku, M., Nomura, N., Akeda, Y., et al. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2337987 · Cited by 4
Gómez‐Moreno, R., González‐Pons, M., Soto‐Salgado, M., Cruz-Correa, M. R., & Baerga‐Ortiz, A. (2019) · Diseases · doi:10.3390/diseases7010016 · Cited by 7
Chang, Y., Li, X., Ding, L., Yang, C., Pan, Z., Han, N., Cui, Y., Zhi, F., Yang, R., Gao, H., et al. (2021) · Engineering · doi:10.1016/j.eng.2021.03.028 · Cited by 4
Mezerová, K., Raclavský, V., & Starý, L. (2021) · Biomedical Papers · doi:10.5507/bp.2021.054 · Cited by 7
Alhadidi, H. A. S., Al-Qaysi, S. A. S., & Al-Halbosiy, M. M. F. (2022) · Microbiology and Biotechnology Letters · doi:10.48022/mbl.2203.03005 · Cited by 5
Meng, X., Chen, Y., Wang, P., Xia, P., Wang, J., He, M., Zhu, C., Wang, H., & Zhu, G. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269102 · Cited by 6
Plitt, T., & Faith, J. J. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101735 · Cited by 3
Capett, M. S., Silva, P. V., Melchiades, V. A., Bokehi, L. C., de Araujo, F. M., Martins, I. S., Neves, F. P. G., Gonzalez, A. G. M., Oswald, É., de Paula, G. R., et al. (2016) · Current Microbiology · doi:10.1007/s00284-016-1104-y · Cited by 5
“Moreover, a hybrid nonribosomal peptide-polyketide compound called colibactin was described [5, 33].”
BackgroundBioactive Molecules of the Human Microbiome
Pauer, H., Glatthardt, T., Ferreira, N. V., Ferreira, R. B. R., & Antunes, L. C. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00012-9 · Cited by 8
The mysteries of macrocyclic colibactins
Carlson, E. S., & Balskus, E. P. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0339-1 · Cited by 5
Frisan, T. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800188-2.00020-3 · Cited by 4
Semisynthetic bioactive organoselenium and organotellurium compounds
Hartwig, D., Jacob, R. G., Lenardao, E. J., Nascimento, J. E. R., Abenante, L., Soares, L. K., & Schiesser, C. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819449-2.00003-3 · Cited by 4
Schwedt, A. (2011) · MPG.PuRe (Max Planck Society) · Cited by 5
Bergsten, E., Mestivier, D., Donnadieu, F., Pédron, T., Barau, C., Tsoumtsa, L. L., Mettouchi, A., Lemichez, E., Gorgette, O., Chamaillard, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.14.491935 · Cited by 4
Jans, M., Kolata, M., Blancke, G., Ciers, M., Dohlman, A. B., Kusakabe, T., Sze, M., Thiran, A., Berx, G., Tejpar, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.16.553526 · Cited by 4
de Klaver, W., de Wit, M., Bolijn, A. S., Tijssen, M., Diemen, P. D., Lemmens, M., Spaander, M. C. W., Dekker, E., van Leerdam, M. E., Coupé, V. M. H., et al. (2024) · The Journal of Pathology · doi:10.1002/path.6276 · Cited by 4
“Colibactin can induce interstrand DNA cross-linking, which can lead to double-strand DNA breaks, chromosome aberrations, and cell-cycle arrest [ 8 – 17].”
BackgroundKim, J., Kim, B., Lee, J., Kim, J., Kwak, J., & Lee, S. H. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1565661 · Cited by 4
“Colibactin produced by E. coli containing a pks island can cause double-strand breaks in mammalian DNA, promoting genome instability and increasing the mutation rate (16, 17).”
Teppabut, W., Tragoolpua, Y., & Kaewkod, T. (2025) · Antibiotics · doi:10.3390/antibiotics14090886 · Cited by 5
Colorectal cancer chemoprevention: Exploring the path from molecular mechanisms to available drugs
Ivy, D. M., Bordone, R., Magno, L. D., Coni, S., & Canettieri, G. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189439 · Cited by 5
Gut microbiota and chemoradiotherapy response in rectal cancer: Biomarker opportunities
Taoum, C., Devaux, A., Rouanet, P., Colombo, P., Boucher, D., & Bonnet, M. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104974 · Cited by 4
Intra-tumoral microbiota: Key modulators of tumor immunity and therapeutic potential
He, J., Tan, H. Z., Qiu, Y., Dan, Y., Wan, Q., Li, L., Wu, J., Song, Q., Chen, H., & Xu, B. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101963 · Cited by 5
“…metastasis Intra-tumoral microbiota can directly stimulate cancer cell proliferation and migration by producing toxins ( e.g. , col-ibactin from E. coli induces DNA double-strand breaks 177 ) or expressing surface adhesins ( e.g. , Fap2 from F. nucleatum activates Wnt/ β -catenin signaling 178 ).”
Jung, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27042068 · Cited by 6
“Consistent with these roles, mutation of any single clb gene (except the expendable clbS ) abolishes colibactin’s genotoxic effects [9,10,15].”
InfluentialAnsari, S., Purohit, K. J., Shelke, A. B., Shah, M., Nkhoma, I. A., Navale, A. M., & Wakchaure, R. S. (2026) · Antonie van Leeuwenhoek · doi:10.1007/s10482-026-02296-9 · Cited by 4
Chemiluminescent Probes Allow for the Rapid Identification of Colibactin-Producing Bacteria
Ramos, M. A. A., Gutkin, S., David, M., Shabat, D., & Balskus, E. P. (2026) · JACS Au · doi:10.1021/jacsau.6c00004 · Cited by 3
“5,6 − 13 Further, mutational signatures arising from colibactin exposure (SBS88, ID18) have been characterized in in vitro eukaryotic models 14,15 and detected in CRC and other cancer genomes, indicating that humans are exposed to colibactin.”
From Microbial Ecology to Functional Components in Microbe–Host Interactions
Wang, T., Wang, Z., Yang, X., & Zhang, L. (2026) · Biology · doi:10.3390/biology15080635 · Cited by 3
“…side, Escherichia coli strains harboring the pks genomic island produce the genotoxin colibactin, which induces host DNA double-strand breaks and generates characteristic mutational signatures; molecular evidence supporting this mechanism has been observed in colorectal cancer tissues [173–176].”
Intratumoral Microbiota in Tumor: Current Understandings and Future Perspectives
Chen, J., Bai, Y., Shen, L., Ying, J., Xu, J. Q., Tang, J., & Bao, Y.-J. (2026) · MedComm · doi:10.1002/mco2.70825 · Cited by 3
“This mechanism has been strongly linked to early colorectal carcinogenesis [ 94–96 ].”
Gut microbiota in health and disease
Li, Y. N., Xiao, X., Jiang, X., Li, X., WANG, W., & Lin, R. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00512-6 · Cited by 8
“Colibactin, produced by pks ⁺ Escherichia coli ( pks ⁺ E. coli ) [137], preferentially targets AAW WTT DNA motifs [138], forming adducts and crosslinks that cause double-strand breaks [139, 140].”
Dhahi, M. A. R. (2024) · Scientific Reports · doi:10.1038/s41598-024-68867-w · Cited by 5
Metadata
- Authors
- Nougayrède, J.-P., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., Buchrieser, C., Hacker, J., Dobrindt, U., & Oswald, E.
- Affiliations
- INRA, UMR1225, Ecole Nationale Vétérinaire de Toulouse, Toulouse F-31076, France.
- Centre National de la Recherche Scientifique (FR)
- Venue
- Science
- Published
- 2006-08-11
- Volume
- 313
- Issue
- 5788
- Pages
- 848-851
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2075479850
- Cited by
- 1,188
- References
- 28
- Citations by year
- 2026: 107 · 2025: 98 · 2024: 103 · 2023: 95 · 2022: 105 · 2021: 127 · 2020: 86 · 2019: 75 · 2018: 56 · 2017: 59 · 2016: 55 · 2015: 44 · 2014: 42 · 2013: 41 · 2012: 14
- FWCI
- 10.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- GRO (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- Escherichia coli, DNA double-strand breaks, megalocytosis, genomic islands, nonribosomal peptide synthetase, polyketide synthase, DNA damage checkpoint, cell cycle arrest, commensal bacteria, extraintestinal pathogenic Escherichia coli, phylogenetic group B2, bacterial pathogenesis, cell death
- MeSH terms
- Animals, Cell Cycle, Cell Line, Cell Nucleus, Cytotoxins, DNA, DNA Damage, DNA-Binding Proteins, Escherichia coli, HeLa Cells, Histones, Humans, Intestinal Mucosa, Molecular Sequence Data, Mutagens, Peptides, Phosphorylation, Signal Transduction, G2 Phase, Mutagenesis, Cell Death, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Tumor Suppressor Proteins, Genomic Islands, Polyketide Synthases, Rats, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.